Tracheo Esophageal Fistula Clinical Trial
Official title:
Trichloroacetic Acid for Endoscopic Tracho-esophageal Fistula Repair
Today Endoscopic repair of recurrent Tracheesophageal fistula (TEF) is a safe procedure.
Using Trichlosiacetic acid 50% (TCA) for endoscopic aplication of the fistula was reported
with a good results ( 4 cases). There were no serious advers effects.
The investigators want to use also TCA 50% for endoscopic repair in children with recurrent
TEF.
Today Endoscopic repair of recurrent Tracheesophageal fistula (TEF) is a safe procedure.
Using Trichlosiacetic acid 50% (TCA) for endoscopic aplication of the fistula was reported
with a good results ( 4 cases). There were no serious advers effects.
We want to use also TCA 50% for endoscopic repair in children with recurrent TEF.
;
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05150600 -
Inverse Ratio Ventilation in Neonatal Open Repair of Tracheoesophageal Fistula.
|
N/A | |
Not yet recruiting |
NCT05847101 -
Outcome Predictors of Trachea-esophageal Fistula
|
||
Not yet recruiting |
NCT04507295 -
Cerebral Blood Flow in Neonates During Thoracoscopic Surgeries
|
N/A |